RALBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.63247193540883E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.72955008490317E-14 |
Normal-vs-Stage2 |
1.6304735339645E-12 |
Normal-vs-Stage3 |
9.99200722162641E-16 |
Normal-vs-Stage4 |
1.62558855265615E-12 |
Stage1-vs-Stage2 |
6.725500E-02 |
Stage1-vs-Stage3 |
3.63520000000728E-05 |
Stage1-vs-Stage4 |
3.776800E-04 |
Stage2-vs-Stage3 |
2.095600E-01 |
Stage2-vs-Stage4 |
2.606800E-01 |
Stage3-vs-Stage4 |
9.861400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63236091310637E-12 |
Normal-vs-AfricanAmerican |
1.64190883111814E-12 |
Normal-vs-Asian |
2.60309995780972E-10 |
Caucasian-vs-AfricanAmerican |
7.053000E-01 |
Caucasian-vs-Asian |
5.674400E-01 |
AfricanAmerican-vs-Asian |
5.513000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.63058455626697E-12 |
Normal-vs-Female |
1.64013247427874E-12 |
Male-vs-Female |
1.944640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.67810210172092E-12 |
Normal-vs-Age(41-60Yrs) |
1.62092561595273E-14 |
Normal-vs-Age(61-80Yrs) |
4.66293670342566E-15 |
Normal-vs-Age(81-100Yrs) |
1.65223390524716E-12 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.034600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.773800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.101800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.274990E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.990400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.014200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.57630020147792E-10 |
Normal-vs-Grade 2 |
4.6074255521944E-14 |
Normal-vs-Grade 3 |
2.55351295663786E-15 |
Normal-vs-Grade 4 |
1.62470037423645E-12 |
Grade 1-vs-Grade 2 |
3.499600E-02 |
Grade 1-vs-Grade 3 |
4.560700E-04 |
Grade 1-vs-Grade 4 |
9.55519999999987E-05 |
Grade 2-vs-Grade 3 |
4.420000E-04 |
Grade 2-vs-Grade 4 |
1.72157999999145E-05 |
Grade 3-vs-Grade 4 |
4.574400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.66566760384512E-12 |
Normal-vs-ccB subtype |
1.62725388719309E-12 |
ccA subtype-vs-ccB subtype |
2.715400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.55031584528842E-15 |
Normal-vs-N1 |
2.49011922193176E-12 |
N0-vs-N1 |
8.765000E-01 |
|
|